Zomedica Corp. (ZOM)
AMEX: ZOM
· Real-Time Price · USD
0.10
0.00 (2.56%)
At close: Mar 04, 2025, 9:50 AM
Zomedica Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
Revenue | 26.73M | 26.08M | 25.97M | 25.19M | 24.01M | 22.43M | 20.66M | 18.93M | 16.85M | 12.1M | 7.87M | 4.13M | 52.33K | 29.82K | 14.12K | n/a | n/a | n/a | n/a |
Cost of Revenue | 11.96M | 12.01M | 10.24M | 9.74M | 7.47M | 6.7M | 5.93M | 5.28M | 4.43M | 3.24M | 2.06M | 1.08M | 59.43K | 41.53K | 5.66K | n/a | n/a | n/a | n/a |
Gross Profit | 14.77M | 14.07M | 15.73M | 15.45M | 16.54M | 15.74M | 14.73M | 13.65M | 12.42M | 8.86M | 5.81M | 3.05M | -7.1K | -11.72K | 8.47K | n/a | n/a | n/a | n/a |
Operating Income | -38.26M | -36.77M | -34.47M | -31.59M | -25.34M | -25.98M | -25.12M | -21.92M | -22.54M | -22.36M | -21.81M | -21.37M | -19.74M | -18.33M | -18.3M | -16.76M | -15.49M | -13.34M | -10.43M |
Interest Income | 4.26M | 4.72M | 5.14M | 5.46M | 5.61M | 5.19M | 4.01M | 2.7M | 1.49M | 574.19K | 409.3K | 357.45K | 272.85K | 199.78K | 87.92K | 32.78K | 21.48K | 247.00 | n/a |
Pretax Income | -62.07M | -57.76M | -39.01M | -35.86M | -17.77M | -21.01M | -21.34M | -19.38M | -21.15M | -21.84M | -20.89M | -20.72M | -19.27M | -17.9M | -18.5M | -16.91M | -15.6M | -13.46M | -10.56M |
Net Income | -62.19M | -55.99M | -37.31M | -34.53M | -14.93M | -19.44M | -19.46M | -17.01M | -17.49M | -18.85M | -18.28M | -18.38M | -19.27M | -17.9M | -18.5M | -16.91M | -15.6M | -13.46M | -10.56M |
Selling & General & Admin | 44.8M | 43.59M | 43.6M | 41.3M | 38.46M | 38.03M | 36.7M | 33M | 32.5M | 29.6M | 26.04M | 22.78M | 17.8M | 13.85M | 10.08M | 8.16M | 6.85M | 6.36M | 6.22M |
Research & Development | 8.22M | 7.24M | 6.6M | 5.74M | 3.42M | 3.69M | 3.15M | 2.58M | 2.47M | 1.62M | 1.58M | 1.64M | 1.81M | 4.22M | 7.86M | 8.08M | 8.03M | 6.29M | 3.44M |
Other Expenses | 21K | 2.22M | 2.16M | 2.08M | 2.19M | -5K | -4K | -4K | 44.38K | 49.98K | 26.78K | 27.78K | -20.46K | -19.09K | 125.95K | 131.45K | 334K | 529.76K | 603.45K |
Operating Expenses | 53.02M | 50.83M | 50.2M | 47.04M | 41.88M | 41.72M | 39.85M | 35.57M | 34.97M | 31.23M | 27.62M | 24.43M | 19.73M | 18.32M | 18.31M | 16.76M | 15.49M | 13.34M | 10.43M |
Interest Expense | n/a | 64K | 126K | 176K | 177K | 1.13M | 1.06M | 1.12M | 1.12M | 110.46K | 116.51K | 9.51K | 6.13K | 6.13K | 81.00 | 732.00 | 651.00 | 651.00 | 12.81K |
Selling & Marketing Expenses | 16.23M | 15.67M | 14.83M | 14.14M | 13.24M | 13.64M | 10.56M | 7.15M | 3.73M | n/a | n/a | n/a | 84.97K | 144.53K | 212.36K | 261.91K | 351.57K | 457.85K | 468.93K |
Cost & Expenses | 64.98M | 62.84M | 60.43M | 56.78M | 49.34M | 48.42M | 45.78M | 40.85M | 39.4M | 34.47M | 29.69M | 25.51M | 19.79M | 18.36M | 18.32M | 16.76M | 15.49M | 13.34M | 10.43M |
Income Tax Expense | 123K | -1.77M | -1.7M | -1.33M | -2.84M | -1.57M | -1.88M | -2.37M | -3.65M | -2.96M | -3.11M | -2.62M | -224.91K | -254.54K | 285.21K | 187.53K | 130.18K | 128.75K | 124.31K |
Shares Outstanding (Basic) | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M | 979.9M | 979.9M | 978.49M | 978.49M | 942.2M | 890.25M | 890.25M | 550.54M | 214.83M | 118.34M |
Shares Outstanding (Diluted) | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M | 979.9M | 979.9M | 978.49M | 978.49M | 973.66M | 890.25M | 890.25M | 550.54M | 214.83M | 118.34M |
EPS (Basic) | -0.06 | -0.06 | -0.04 | -0.04 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.04 | -0.06 | -0.08 | -0.1 | -0.09 |
EPS (Diluted) | -0.06 | -0.06 | -0.04 | -0.04 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.04 | -0.06 | -0.08 | -0.1 | -0.09 |
EBITDA | -54.27M | -50.32M | -32.02M | -29.39M | -11.94M | -15.68M | -16.71M | -15.34M | -17.51M | -19.32M | -19.72M | -20.09M | -19.35M | -17.91M | -17.86M | -16.38M | -14.98M | -12.77M | -9.8M |
EBIT | -62.07M | -57.69M | -38.88M | -35.69M | -16.33M | -19.64M | -20.03M | -18.11M | -21.15M | -21.9M | -21.58M | -21.23M | -19.78M | -18.35M | -18.33M | -16.91M | -15.59M | -13.46M | -10.54M |
Depreciation & Amortization | 7.81M | 7.37M | 6.87M | 6.3M | 5.66M | 5.22M | 4.58M | 4.04M | 3.63M | 2.58M | 1.85M | 1.14M | 431.04K | 447.46K | 469.77K | 530.02K | 614.04K | 688.16K | 761.85K |